CDC said to delay vaccine panel meeting after lawsuit challenging its composition
Source: SeekingAlpha
2026-02-19 14:10:21 ET
More on Pfizer, Sanofi, etc.
- Pfizer: Recovery Isn't Over, Battered Valuation Still Discounts Its Turnaround Game
- Pfizer: The Rebound Looks Unsustainable
- GSK: Post-Pivot Buoyancy Set To Continue After Strong 2025 (Upgrade)
- China drug licensing deals surge nearly 10-fold in value since 2021
- NIH director reportedly being tapped as acting CDC director
Read the full article on Seeking Alpha
For further details see:
CDC said to delay vaccine panel meeting after lawsuit challenging its composition
Moderna Inc.
NASDAQ: MRNA
MRNA Trading
-5.05% G/L:
$54.20 Last:
3,023,054 Volume:
$54.75 Open:
MRNA Latest News
MRNA Stock Data
$16,877,354,918
348,095,445
0.39%
298
N/A
Biotechnology & Life Sciences
Healthcare
US
Cambridge
